Search for: "DR. REDDY'S LABORATORIES, INC."
Results 1 - 20
of 102
Sort by Relevance
|
Sort by Date
13 Feb 2024, 9:58 am
Reddy’s Laboratories S.A., 18 F.4th 1323 (Fed. [read post]
27 Dec 2021, 7:02 am
Prem Reddy, and California interventional cardiologist Dr. [read post]
3 Dec 2021, 2:39 pm
Reddy’s Laboratories Inc., 923 F.3d 1368, 1376 (Fed. [read post]
27 Nov 2021, 2:12 pm
Reddy’s Laboratories, Inc. [read post]
20 Jan 2021, 12:58 pm
Reddy’s Laboratories Inc., may not be relevant to any other case, but it caught my attention as an example of the perils of claim drafting. [read post]
6 Jan 2021, 8:17 pm
The meaning of the statute was most recently explicated by the Supreme Court in Nautilus, Inc. v. [read post]
3 Sep 2020, 9:23 pm
Reddy's Laboratories, Inc., and Dr. [read post]
16 Jun 2020, 9:59 pm
Reddy's Laboratories, S.A.). [read post]
4 Jun 2020, 2:58 am
Reddy’s Laboratories, Ltd. v. [read post]
30 Mar 2020, 10:00 pm
Reddy’s Laboratories (DRL) from launching generic competitor drugs to Vascepa, and the Defendants counter-claimed that Amarin’s six patents were invalid as obvious, among other things. [read post]
26 Mar 2020, 7:00 am
Reddy’s Laboratories, Ltd. v. [read post]
18 Mar 2020, 9:55 pm
Reddy's Laboratories, S.A.; and UCB, Inc. v. [read post]
17 Mar 2020, 1:32 pm
Lidocaine HCl Topical Solution 4%, 50ml, has been recalled by Teligent Pharma, Inc. due to super potency. [read post]
13 Jan 2020, 7:55 am
Reddy’s Laboratories, et al., No. 19-584 (written description need for experimental data proving claimed effectiveness) Mushkin, Inc. v. [read post]
27 Aug 2019, 9:59 pm
By Kevin E. [read post]
27 Aug 2019, 2:03 am
Reddy’s Laboratories Inc., which seemed to impose a higher standard for satisfying the written description requirement, the Federal Circuit decision in Nalpropion Pharmaceuticals, Inc. v. [read post]
19 Aug 2019, 11:39 am
Reddy’s Laboratories, Inc. and Fresenius, 2018-1804, 2019 WL 3807979 (Fed. [read post]
12 Aug 2019, 9:54 pm
Dr. [read post]
24 Jul 2019, 9:46 pm
Reddy's Laboratories, S.A. [read post]
24 Jul 2019, 10:03 am
Reddy’s Laboratories Inc., Docket No. 17-02473 (Fed. [read post]